FDA Inspection 1009909 — Biowave Corporation

Biowave Corporation — FEI 3004558433

The FDA completed an inspection of Biowave Corporation on Apr 27, 2017 in Westport, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 27, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Westport, CT (United States)

Citations

IDCFRDescription
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
366621 CFR 820.20(c)Management review - Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.